Specialty Pharmacy Times: January/February

From the Chairman
Approvals and Access Highlight the Year Ahead in Specialty
Following a year in which nearly 40 specialty drugs were approved by the FDA, 2019 also is expected to be huge in the specialty market, with more therapies for cancer, multiple sclerosis, and orphan conditions on the horizon.
Top Trends for 2019 In Specialty
Not a day goes by without a health care–related headline, and our industry continues to be influenced by change, some positive and some less so.
In Practice
Manufacturer Reimbursement Support Programs Raise Legal Questions For Specialty Pharmacies
Navigating insurance coverage for specialty drugs has always been a complex and fundamental part of the specialty drug distribution chain.
2019 Specialty Pipeline Highlights
Keep an eye out for these specialty pipeline medications in 2019.
Actions Following the FDA Compounding Priorities Plan
For a current compounder or someone looking to enter the space, it is imperative that their business remains on top of the latest compounding developments.
Looking Beyond the Eye of the Storm: Specialty Pharmacy After Disaster
Unfortunately, there is no way to stop a category 5 hurricane, but it doesn’t have to result in catastrophe for patients.
How Can We Advance Progress in Moving From Volume to Value in Health Care?
It is critical that we continue to recognize that better health outcomes are a critically important corollary to value.
A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019
There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.
USP Ushers in Sweeping Changes to Rules for Hospital and Retail Pharmacies
They may still suggest revisions to latest standards but must prepare regardless for new compounding regulations.
Clinical Insights
Emerging Therapies for Hemophilia A and B
Although the leading treatment for hemophilia is a replacement therapy in the form of both plasma-derived and rF products, research is underway for the discovery of novel agents.
The Pharmacist’s Role in Maximizing HIV Antiretroviral Therapy
Through ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.